The interactions between a low molecular weight protease inhibitor of bronchial mucus and chymotrypsin-like cationic proteins of granulocytes.
The proteolytic activity of the chymotrypsin-like cationic proteins of human granulocytes is inhibited by complex formation with the acid-stable low molecular weight protease inhibitor of human bronchial mucus (Ki = 1.0 x 10(7)M). The molar combining ratio is 1:1.
D001980:Bronchi / Q000201:enzymology*; D002918:Chymotrypsin / Q000097:blood*; D006098:Granulocytes / Q000201:enzymology*; D006801:Humans; D007962:Leukocytes / Q000201:enzymology*; D008970:Molecular Weight; D009092:Mucous Membrane / Q000201:enzymology; D011480:Protease Inhibitors; D014361:Trypsin Inhibitors / Q000378:metabolism
D011480:Protease Inhibitors; D014361:Trypsin Inhibitors; D002918:Chymotrypsin